Division of Medical Genetics, Department of Pediatrics, Duke Medicine, Durham, NC 27713, USA.
Mol Genet Metab. 2012 Mar;105(3):519-21. doi: 10.1016/j.ymgme.2011.12.011. Epub 2011 Dec 21.
Mucopolysaccharidosis type II (MPS II) or Hunter syndrome is a lysosomal storage disease caused by deficiency of iduronate-2-sulfatase (IDS). A convenient single-step fluorometric microplate enzyme assay has been developed and validated for clinical diagnosis of MPS II using dried blood spots (DBS). The assay compared well with a recently reported digital microfluidic method, from which it was adapted. Results show that this DBS assay is robust and reproducible using both technologies.
黏多糖贮积症 II 型(MPS II)或亨特综合征是一种溶酶体贮积病,由艾度糖-2-硫酸酯酶(IDS)缺乏引起。已经开发并验证了一种方便的一步荧光微孔板酶分析法,用于使用干血斑(DBS)进行 MPS II 的临床诊断。该测定法与最近报道的数字微流控方法相比,该方法是从该方法改编而来的。结果表明,这两种技术都使 DBS 测定法具有稳健性和可重复性。